Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations? Authors' reply
- PMID: 38153285
- DOI: 10.1111/apt.17810
Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations? Authors' reply
Comment on
-
Editorial: Does knowledge about liver disease enhance adherence to lifestyle recommendations?Aliment Pharmacol Ther. 2024 Jan;59(2):283-284. doi: 10.1111/apt.17789. Aliment Pharmacol Ther. 2024. PMID: 38153277 No abstract available.
References
REFERENCES
-
- Michel M, Schattenberg J. Editorial: does knowledge about liver disease enhance adherence to lifestyle recommendations? Aliment Pharmacol Ther. 2024;59:283-284.
-
- Petroni ML, Colosimo S, Brodosi L, Armandi A, Bertini F, Montesi D, et al. Long-term follow-up of web-based and group-based behavioural intervention in NAFLD in a real world clinical setting. Aliment Pharmacol Ther. 2024;59:249-259. https://doi.org/10.1111/apt.17768
-
- Anstee QM, Berentzen TL, Nitze LM, Jara M, Jensen AB, Kjaer MS, et al. Fibrosis-4 index is associated with subsequent risk of liver events, cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: results from a longitudinal cohort study. Lancet Reg Health Eur. 2023.
-
- Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol. 2015;49:690-696. https://doi.org/10.1097/MCG.0000000000000208
-
- Wong RJ, Kachru N, Martinez DJ, Moynihan M, Ozbay AB, Gordon SC. Real-world comorbidity burden, health care utilization, and costs of nonalcoholic steatohepatitis patients with advanced liver diseases. J Cin Gastroenterol. 2021;55:891-902. https://doi.org/10.1097/MCG.0000000000001409
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical